Skip to main content
Erschienen in: Inflammation 1/2012

01.02.2012

Subacute Inflammatory Activation in Subjects with Acute Coronary Syndrome and Left Ventricular Dysfunction

verfasst von: Luisa De Gennaro, Natale Daniele Brunetti, Deodata Montrone, Fiorella De Rosa, Andrea Cuculo, Matteo Di Biase

Erschienen in: Inflammation | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Several lines of evidence indicate that increased inflammatory cytokine levels can be used for risk prediction in patients with acute coronary syndrome (ACS). This study therefore aimed to evaluate correlations between levels of soluble interleukin (IL)-2 receptor (sIL-2r), IL-6, and IL-8 and in-hospital incidence of acute heart failure (AHF) and left ventricular (LV) systolic dysfunction in the subacute phase of ACS. In 48 consecutive patients with ACS, circulating levels of sIL-2r, IL-6, and IL-8 were ascertained 72–96 h after onset of symptoms. Clinical data, LV function, and in-hospital incidence of AHF were also evaluated. IL-8 levels were significantly higher in patients with pulmonary edema (1,829 ± 2,496 vs 456 ± 624 pg/ml, p < 0.05); sIL-2r, IL-6, and IL-8 levels were increased proportionally to Killip class (r = 0.35, p < 0.05; r = 0.48, r = 0.47, p < 0.01) and in patients with LV ejection fraction (LVEF) < 30%. Levels of sIL-2r were inversely related to LVEF in subjects with acute myocardial infarction (r = −0.51, p < 0.05). Soluble IL-2r and IL-8 levels were related to mitral regurgitation severity (r = 0.34, p < 0.05; r = 0.37, p < 0.05). Levels of sIL-2 were proportional to LV end-diastolic diameter (r = 0.49, p < 0.001) and LV end-systolic diameter (r = 0.58, p < 0.001). Number of cytokines with circulating values above upper level of normal was significantly correlated with Killip class and LVEF (r = 0.40, r = −0.38, p < 0.05). sIL-2r, IL-6, and IL-8 are increased in patients with ACS and systolic dysfunction or AHF. These data suggest that inflammatory cytokine activity detectable in peripheral blood may be useful in identifying subjects with a worse clinical course.
Literatur
1.
Zurück zum Zitat Biasucci, L.M., A. Vitelli, G. Liuzzo, S. Altamura, G. Caligiuri, C. Monaco, A.G. Rebuzzi, G. Ciliberto, and A. Maseri. 1996. Elevated levels of IL-6 in unstable angina. Circulation 94: 874–877.PubMed Biasucci, L.M., A. Vitelli, G. Liuzzo, S. Altamura, G. Caligiuri, C. Monaco, A.G. Rebuzzi, G. Ciliberto, and A. Maseri. 1996. Elevated levels of IL-6 in unstable angina. Circulation 94: 874–877.PubMed
2.
Zurück zum Zitat Manten, A., R.J. de Winter, M.C. Minnema, H. ten Cate, J.G. Lijmer, R. Adams, R.J. Peters, and S.J. van Deventer. 1998. Procoagulant and proinflammatory activity in acute coronary syndromes. Cardiovascular Research 40: 389–395.PubMedCrossRef Manten, A., R.J. de Winter, M.C. Minnema, H. ten Cate, J.G. Lijmer, R. Adams, R.J. Peters, and S.J. van Deventer. 1998. Procoagulant and proinflammatory activity in acute coronary syndromes. Cardiovascular Research 40: 389–395.PubMedCrossRef
3.
Zurück zum Zitat Biasucci, L.M., G. Liuzzo, A. Fantuzzi, G. Caligiuri, A.G. Rebuzzi, F. Ginetti, C.A. Dinarello, and A. Maseri. 1999. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first two days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 99: 2079–2084.PubMed Biasucci, L.M., G. Liuzzo, A. Fantuzzi, G. Caligiuri, A.G. Rebuzzi, F. Ginetti, C.A. Dinarello, and A. Maseri. 1999. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first two days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 99: 2079–2084.PubMed
4.
Zurück zum Zitat Simon, A.D., S. Yazdani, W. Wang, A. Schwartz, and L.E. Rabbani. 2000. Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina. Journal of Thrombosis and Thrombolysis 9: 217–222.PubMedCrossRef Simon, A.D., S. Yazdani, W. Wang, A. Schwartz, and L.E. Rabbani. 2000. Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina. Journal of Thrombosis and Thrombolysis 9: 217–222.PubMedCrossRef
6.
Zurück zum Zitat Sato, Y., Y. Takatsu, K. Kataoka, et al. 1999. Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clinical Cardiology 22: 811–813.PubMedCrossRef Sato, Y., Y. Takatsu, K. Kataoka, et al. 1999. Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clinical Cardiology 22: 811–813.PubMedCrossRef
7.
Zurück zum Zitat Puhakka, M., J. Magga, S. Hietakorpi, I. Penttilä, P. Uusimaa, J. Risteli, and K. Peuhkurinen. 2003. Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation. Journal of Cardiac Failure 9: 325–332.PubMedCrossRef Puhakka, M., J. Magga, S. Hietakorpi, I. Penttilä, P. Uusimaa, J. Risteli, and K. Peuhkurinen. 2003. Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation. Journal of Cardiac Failure 9: 325–332.PubMedCrossRef
8.
Zurück zum Zitat Brunetti, N.D., R. Troccoli, M. Correale, P.L. Pellegrino, and M. Di Biase. 2006. C-reactive protein in patients with acute coronary syndrome: Correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. International Journal of Cardiology 109: 248–256.PubMedCrossRef Brunetti, N.D., R. Troccoli, M. Correale, P.L. Pellegrino, and M. Di Biase. 2006. C-reactive protein in patients with acute coronary syndrome: Correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. International Journal of Cardiology 109: 248–256.PubMedCrossRef
9.
Zurück zum Zitat Thaik, C.M., A. Calderone, N. Takahashi, and W.S. Colucci. 1995. Interleukin-1b modulates the growth and phenotype of neonatal rat cardiac myocytes. Journal of Clinical Investigation 96: 1093–1099.PubMedCrossRef Thaik, C.M., A. Calderone, N. Takahashi, and W.S. Colucci. 1995. Interleukin-1b modulates the growth and phenotype of neonatal rat cardiac myocytes. Journal of Clinical Investigation 96: 1093–1099.PubMedCrossRef
10.
Zurück zum Zitat Kubota, T., C.F. McTiernan, C.S. Frye, S.E. Slawson, B.H. Lemster, A.P. Koretsky, A.J. Demetris, and A.M. Feldman. 1997. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circulation Research 81: 627–635.PubMed Kubota, T., C.F. McTiernan, C.S. Frye, S.E. Slawson, B.H. Lemster, A.P. Koretsky, A.J. Demetris, and A.M. Feldman. 1997. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circulation Research 81: 627–635.PubMed
11.
Zurück zum Zitat Seta, Y., K. Shan, B. Bozkurt, H. Oral, and D.L. Mann. 1996. Basic mechanisms in heart failure: The cytokine hypothesis. Journal of Cardiac Failure 2: 243–249.PubMedCrossRef Seta, Y., K. Shan, B. Bozkurt, H. Oral, and D.L. Mann. 1996. Basic mechanisms in heart failure: The cytokine hypothesis. Journal of Cardiac Failure 2: 243–249.PubMedCrossRef
12.
Zurück zum Zitat van Deventer, S.J., H.R. Büller, J.W. ten Cate, L.A. Aarden, C.E. Hack, and A. Sturk. 1990. Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 76: 2520–2526.PubMed van Deventer, S.J., H.R. Büller, J.W. ten Cate, L.A. Aarden, C.E. Hack, and A. Sturk. 1990. Experimental endotoxemia in humans: Analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 76: 2520–2526.PubMed
13.
Zurück zum Zitat Ng, S.B., Y.N. Tan, and G.R. Guy. 1994. Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. The Journal of Biological Chemistry 269: 19021–19027.PubMed Ng, S.B., Y.N. Tan, and G.R. Guy. 1994. Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. The Journal of Biological Chemistry 269: 19021–19027.PubMed
14.
Zurück zum Zitat Sanceau, J., T. Kaisho, T. Hirano, and J. Wietzerbin. 1995. Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocyte cells involves cooperation between interferon regulatory factor-1, NFkB, and SP1 transcription factors. The Journal of Biological Chemistry 270: 27920–27931.PubMedCrossRef Sanceau, J., T. Kaisho, T. Hirano, and J. Wietzerbin. 1995. Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocyte cells involves cooperation between interferon regulatory factor-1, NFkB, and SP1 transcription factors. The Journal of Biological Chemistry 270: 27920–27931.PubMedCrossRef
15.
Zurück zum Zitat Baumann, H., and J. Gauldie. 1990. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Molecular Biology & Medicine 7: 147–159. Baumann, H., and J. Gauldie. 1990. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Molecular Biology & Medicine 7: 147–159.
16.
Zurück zum Zitat Heinrich, P.C., J.V. Castell, and T. Andus. 1990. Interleukin-6 and the acute phase response. The Biochemical Journal 265: 621–636.PubMed Heinrich, P.C., J.V. Castell, and T. Andus. 1990. Interleukin-6 and the acute phase response. The Biochemical Journal 265: 621–636.PubMed
17.
Zurück zum Zitat Tsutamoto, T., T. Hisanaga, A. Wada, K. Maeda, M. Ohnishi, D. Fukai, N. Mabuchi, M. Sawaki, and M. Kinoshita. 1998. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. Journal of the American College of Cardiology 31: 391–398.PubMedCrossRef Tsutamoto, T., T. Hisanaga, A. Wada, K. Maeda, M. Ohnishi, D. Fukai, N. Mabuchi, M. Sawaki, and M. Kinoshita. 1998. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. Journal of the American College of Cardiology 31: 391–398.PubMedCrossRef
18.
Zurück zum Zitat Testa, M., M. Yeh, P. Lee, R. Fanelli, F. Loperfido, J.W. Berman, and T.H. Le Jemtel. 1996. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. Journal of the American College of Cardiology 28: 964–971.PubMedCrossRef Testa, M., M. Yeh, P. Lee, R. Fanelli, F. Loperfido, J.W. Berman, and T.H. Le Jemtel. 1996. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. Journal of the American College of Cardiology 28: 964–971.PubMedCrossRef
19.
Zurück zum Zitat Torre-Amione, G., S. Kapadia, C. Benedict, H. Oral, J.B. Young, and D.L. Mann. 1996. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD). Journal of the American College of Cardiology 27: 1201–1206.PubMedCrossRef Torre-Amione, G., S. Kapadia, C. Benedict, H. Oral, J.B. Young, and D.L. Mann. 1996. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD). Journal of the American College of Cardiology 27: 1201–1206.PubMedCrossRef
20.
Zurück zum Zitat Mohler 3rd, E.R., L.C. Sorensen, J.K. Ghali, D.D. Schocken, P.W. Willis, J.A. Bowers, A.B. Cropp, and M.L. Pressler. 1997. Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial: Prospective Randomized Amlodipine Survival Evaluation. Journal of the American College of Cardiology 30: 35–41.PubMedCrossRef Mohler 3rd, E.R., L.C. Sorensen, J.K. Ghali, D.D. Schocken, P.W. Willis, J.A. Bowers, A.B. Cropp, and M.L. Pressler. 1997. Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial: Prospective Randomized Amlodipine Survival Evaluation. Journal of the American College of Cardiology 30: 35–41.PubMedCrossRef
21.
Zurück zum Zitat Deswal, A., N.J. Petersen, A.M. Feldman, B.G. White, and D.L. Mann. 2001. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103: 2055–2059.PubMed Deswal, A., N.J. Petersen, A.M. Feldman, B.G. White, and D.L. Mann. 2001. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103: 2055–2059.PubMed
22.
Zurück zum Zitat Sugishita, K., K. Kinugawa, T. Shimizu, K. Harada, H. Matsui, T. Takahashi, T. Serizawa, and O. Kohmoto. 1999. Cellular basis for the acute inhibitory effects of IL-6 and TNF on excitation–contraction coupling. Journal of Molecular and Cellular Cardiology 31: 1457–1467.PubMedCrossRef Sugishita, K., K. Kinugawa, T. Shimizu, K. Harada, H. Matsui, T. Takahashi, T. Serizawa, and O. Kohmoto. 1999. Cellular basis for the acute inhibitory effects of IL-6 and TNF on excitation–contraction coupling. Journal of Molecular and Cellular Cardiology 31: 1457–1467.PubMedCrossRef
23.
Zurück zum Zitat Suzuki, H., R. Sato, T. Sato, M. Shoji, Y. Iso, T. Kondo, M. Shibata, S. Koba, and T. Katagiri. 2005. Time-course of changes in the levels of interleukin 6 in acutely decompensated heart failure. International Journal of Cardiology 100: 415–420.PubMedCrossRef Suzuki, H., R. Sato, T. Sato, M. Shoji, Y. Iso, T. Kondo, M. Shibata, S. Koba, and T. Katagiri. 2005. Time-course of changes in the levels of interleukin 6 in acutely decompensated heart failure. International Journal of Cardiology 100: 415–420.PubMedCrossRef
24.
Zurück zum Zitat Chin, B.S., D.S. Conway, N.A. Chung, A.D. Blann, C.R. Gibbs, and G.Y. Lip. 2003. Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: Relationship to treatment and prognosis. Blood Coagulation & Fibrinolysis 14: 515–521.CrossRef Chin, B.S., D.S. Conway, N.A. Chung, A.D. Blann, C.R. Gibbs, and G.Y. Lip. 2003. Interleukin-6, tissue factor and von Willebrand factor in acute decompensated heart failure: Relationship to treatment and prognosis. Blood Coagulation & Fibrinolysis 14: 515–521.CrossRef
25.
Zurück zum Zitat Damås, J.K., H.G. Eiken, E. Oie, V. Bjerkeli, A. Yndestad, T. Ueland, T. Tonnessen, O.R. Geiran, H. Aass, S. Simonsen, G. Christensen, S.S. Froland, H. Attramadal, L. Gullestad, and P. Aukrust. 2000. Myocardial expression of CC and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovascular Research 47: 778–787.PubMedCrossRef Damås, J.K., H.G. Eiken, E. Oie, V. Bjerkeli, A. Yndestad, T. Ueland, T. Tonnessen, O.R. Geiran, H. Aass, S. Simonsen, G. Christensen, S.S. Froland, H. Attramadal, L. Gullestad, and P. Aukrust. 2000. Myocardial expression of CC and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovascular Research 47: 778–787.PubMedCrossRef
26.
Zurück zum Zitat Xu, L., D.J. Kelvin, G.O. Ye, D.D. Taub, A. Ben-Baruch, J.J. Oppenheim, and J.M. Wang. 1995. Modulation of IL-8 receptor expression on purified human lymphocytes is associated with changed chemotactic responses to IL-8. Journal of Leukocyte Biology 57: 335–342.PubMed Xu, L., D.J. Kelvin, G.O. Ye, D.D. Taub, A. Ben-Baruch, J.J. Oppenheim, and J.M. Wang. 1995. Modulation of IL-8 receptor expression on purified human lymphocytes is associated with changed chemotactic responses to IL-8. Journal of Leukocyte Biology 57: 335–342.PubMed
27.
Zurück zum Zitat Gerszten, R.E., E.A. Garcia-Zepeda, Y.C. Lim, M. Yoshida, H.A. Ding, M.A. Gimbrone Jr., A.D. Luster, F.W. Luscinskas, and A. Rosenzweig. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398: 718–723.PubMedCrossRef Gerszten, R.E., E.A. Garcia-Zepeda, Y.C. Lim, M. Yoshida, H.A. Ding, M.A. Gimbrone Jr., A.D. Luster, F.W. Luscinskas, and A. Rosenzweig. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398: 718–723.PubMedCrossRef
28.
Zurück zum Zitat Yue, T.L., X. Wang, C.P. Sung, B. Olson, P.J. McKenna, J.L. Gu, and G.Z. Feuerstein. 1994. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circulation Research 75: 1–7.PubMed Yue, T.L., X. Wang, C.P. Sung, B. Olson, P.J. McKenna, J.L. Gu, and G.Z. Feuerstein. 1994. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. Circulation Research 75: 1–7.PubMed
29.
Zurück zum Zitat Moreau, M., I. Brocheriou, L. Petit, E. Ninio, M.J. Chapman, and M. Rouis. 1999. IL-8 mediates down-regulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: Relevance to stability of atherosclerotic plaque. Circulation 99: 420–426.PubMed Moreau, M., I. Brocheriou, L. Petit, E. Ninio, M.J. Chapman, and M. Rouis. 1999. IL-8 mediates down-regulation of tissue inhibitor of metalloproteinase-1 expression in cholesterol-loaded human macrophages: Relevance to stability of atherosclerotic plaque. Circulation 99: 420–426.PubMed
30.
Zurück zum Zitat Purushothaman, K.R., V. Fuster, W.N. O’Connor, and P.R. Moreno. 2003. Neovascularization is the most powerful independent predictor for progression to disruption in high risk atherosclerotic plaques. Journal of the American College of Cardiology 41: 352–353.CrossRef Purushothaman, K.R., V. Fuster, W.N. O’Connor, and P.R. Moreno. 2003. Neovascularization is the most powerful independent predictor for progression to disruption in high risk atherosclerotic plaques. Journal of the American College of Cardiology 41: 352–353.CrossRef
31.
Zurück zum Zitat Moreno, P.R., K.R. Purushothaman, V. Fuster, D. Echeverri, H. Truszczynska, S.K. Sharma, J.J. Badimon, and W.N. O’Connor. 2004. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta. Implications for plaque vulnerability. Circulation 110: 2032–2038.PubMedCrossRef Moreno, P.R., K.R. Purushothaman, V. Fuster, D. Echeverri, H. Truszczynska, S.K. Sharma, J.J. Badimon, and W.N. O’Connor. 2004. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta. Implications for plaque vulnerability. Circulation 110: 2032–2038.PubMedCrossRef
32.
Zurück zum Zitat Virmani, R., F.D. Kolodgie, A.P. Burke, A.V. Finn, H.K. Gold, T.N. Tulenko, S.P. Wrenn, and J. Narula. 2005. Atherosclerotic plaque progression and vulnerability to rupture: Angiogenesis as a source of intraplaque hemorrhage. Arteriosclerosis, Thrombosis, and Vascular Biology 25: 2054–2061.PubMedCrossRef Virmani, R., F.D. Kolodgie, A.P. Burke, A.V. Finn, H.K. Gold, T.N. Tulenko, S.P. Wrenn, and J. Narula. 2005. Atherosclerotic plaque progression and vulnerability to rupture: Angiogenesis as a source of intraplaque hemorrhage. Arteriosclerosis, Thrombosis, and Vascular Biology 25: 2054–2061.PubMedCrossRef
33.
Zurück zum Zitat Johnson, K., L.A. Aarden, Y. Choi, E. De Groot, and A. Creasey. 1996. The proinflammatory cytokine response to coagulation and endotoxin in whole blood. Blood 12: 5051–5060. Johnson, K., L.A. Aarden, Y. Choi, E. De Groot, and A. Creasey. 1996. The proinflammatory cytokine response to coagulation and endotoxin in whole blood. Blood 12: 5051–5060.
34.
Zurück zum Zitat Aukrust, P., T. Ueland, F. Müller, A.K. Andreassen, I. Nordøy, H. Aas, J. Kjekshus, S. Simonsen, S.S. Frøland, and L. Gullestad. 1998. Elevated circulating levels of CC chemokines in patients with congestive heart failure. Circulation 97: 1136–1143.PubMed Aukrust, P., T. Ueland, F. Müller, A.K. Andreassen, I. Nordøy, H. Aas, J. Kjekshus, S. Simonsen, S.S. Frøland, and L. Gullestad. 1998. Elevated circulating levels of CC chemokines in patients with congestive heart failure. Circulation 97: 1136–1143.PubMed
35.
Zurück zum Zitat Damås, J.K., L. Gullestad, T. Ueland, N.O. Solum, S. Simonsen, S.S. Frøland, and P. Aukrust. 2000. CXC-chemokines, a new group of cytokines in congestive heart failure—possible role of platelets and monocytes. Cardiovascular Research 45: 428–436.PubMedCrossRef Damås, J.K., L. Gullestad, T. Ueland, N.O. Solum, S. Simonsen, S.S. Frøland, and P. Aukrust. 2000. CXC-chemokines, a new group of cytokines in congestive heart failure—possible role of platelets and monocytes. Cardiovascular Research 45: 428–436.PubMedCrossRef
36.
Zurück zum Zitat Damås, J.K., L. Gullestad, H. Aass, S. Simonsen, J.G. Fjeld, L. Wikeby, T. Ueland, H.G. Eiken, S.S. Frøland, and P. Aukrust. 2001. Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure—modulatory effect of intravenous immunoglobulin. Journal of the American College of Cardiology 38: 187–193.PubMedCrossRef Damås, J.K., L. Gullestad, H. Aass, S. Simonsen, J.G. Fjeld, L. Wikeby, T. Ueland, H.G. Eiken, S.S. Frøland, and P. Aukrust. 2001. Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure—modulatory effect of intravenous immunoglobulin. Journal of the American College of Cardiology 38: 187–193.PubMedCrossRef
37.
Zurück zum Zitat Limas, C.J., I.F. Goldenberg, and C. Limas. 1995. Soluble interleukin 2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies. Circulation 91: 631–634.PubMed Limas, C.J., I.F. Goldenberg, and C. Limas. 1995. Soluble interleukin 2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies. Circulation 91: 631–634.PubMed
38.
Zurück zum Zitat Young, J.B., N.T. Windsor, F.W. Smart, N.S. Kleiman, D.G. Weilbaecher, G.P. Noon, D.L. Nelson, and E.C. Lawrence. 1991. Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantation. Transplantation 51: 636–641.PubMedCrossRef Young, J.B., N.T. Windsor, F.W. Smart, N.S. Kleiman, D.G. Weilbaecher, G.P. Noon, D.L. Nelson, and E.C. Lawrence. 1991. Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantation. Transplantation 51: 636–641.PubMedCrossRef
39.
Zurück zum Zitat Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annual Review of Immunology 12: 227–257.PubMedCrossRef Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annual Review of Immunology 12: 227–257.PubMedCrossRef
40.
Zurück zum Zitat Ferrari, R., T. Bachetti, R. Confortini, C. Opasich, O. Febo, A. Corti, G. Cassani, and O. Visioli. 1995. Tumor necrosis factor soluble receptors in patients with various degrees of chronic heart failure. Circulation 92: 1479–1486.PubMed Ferrari, R., T. Bachetti, R. Confortini, C. Opasich, O. Febo, A. Corti, G. Cassani, and O. Visioli. 1995. Tumor necrosis factor soluble receptors in patients with various degrees of chronic heart failure. Circulation 92: 1479–1486.PubMed
41.
Zurück zum Zitat Kelly, R.A., and T.W. Smith. 1997. Cytokines and cardiac contractile function. Circulation 95: 778–781.PubMed Kelly, R.A., and T.W. Smith. 1997. Cytokines and cardiac contractile function. Circulation 95: 778–781.PubMed
42.
Zurück zum Zitat de Belder, A.J., M.W. Radomski, H.J. Why, P.J. Richardson, C.A. Bucknall, E. Salas, J.F. Martin, and S. Moncada. 1993. Nitric oxide synthase activities in human myocardium. Lancet 341: 84–85.PubMedCrossRef de Belder, A.J., M.W. Radomski, H.J. Why, P.J. Richardson, C.A. Bucknall, E. Salas, J.F. Martin, and S. Moncada. 1993. Nitric oxide synthase activities in human myocardium. Lancet 341: 84–85.PubMedCrossRef
43.
Zurück zum Zitat Haywood, G.A., P.S. Tsao, H.E. von der Leyen, M.J. Mann, P.J. Keeling, P.T. Trindade, N.P. Lewis, C.D. Byrne, P.R. Rickenbacher, N.H. Bishopric, J.P. Cooke, W.J. McKenna, and M.B. Fowler. 1996. Expression of inducible nitric oxide synthase in human heart failure. Circulation 93: 1087–1094.PubMed Haywood, G.A., P.S. Tsao, H.E. von der Leyen, M.J. Mann, P.J. Keeling, P.T. Trindade, N.P. Lewis, C.D. Byrne, P.R. Rickenbacher, N.H. Bishopric, J.P. Cooke, W.J. McKenna, and M.B. Fowler. 1996. Expression of inducible nitric oxide synthase in human heart failure. Circulation 93: 1087–1094.PubMed
44.
Zurück zum Zitat Narula, J., N. Haider, R. Virmani, T.G. DiSalvo, F.D. Kolodgie, R.J. Hajjar, U. Schmidt, M.J. Semigran, G.W. Dec, and B.A. Khaw. 1996. Apoptosis in myocytes in end-stage heart failure. The New England Journal of Medicine 335: 1182–1189.PubMedCrossRef Narula, J., N. Haider, R. Virmani, T.G. DiSalvo, F.D. Kolodgie, R.J. Hajjar, U. Schmidt, M.J. Semigran, G.W. Dec, and B.A. Khaw. 1996. Apoptosis in myocytes in end-stage heart failure. The New England Journal of Medicine 335: 1182–1189.PubMedCrossRef
45.
Zurück zum Zitat Olivetti, G., R. Abbi, F. Quaini, J. Kajstura, W. Cheng, J.A. Nitahara, E. Quaini, C. Di Loreto, C.A. Beltrami, S. Krajewski, J.C. Reed, and P. Anversa. 1997. Apoptosis in the failing human heart. The New England Journal of Medicine 336: 1131–1141.PubMedCrossRef Olivetti, G., R. Abbi, F. Quaini, J. Kajstura, W. Cheng, J.A. Nitahara, E. Quaini, C. Di Loreto, C.A. Beltrami, S. Krajewski, J.C. Reed, and P. Anversa. 1997. Apoptosis in the failing human heart. The New England Journal of Medicine 336: 1131–1141.PubMedCrossRef
46.
Zurück zum Zitat Brunetti, N.D., R. Padalino, L. De Gennaro, A. Cuculo, L. Ziccardi, P.L. Pellegrino, and M. Di Biase. 2009. Acute phase proteins activation in subjects with coronary atherosclerosis and micro-vessel coronary circulation impairment. Journal of Thrombosis and Thrombolysis 28: 50–56.PubMedCrossRef Brunetti, N.D., R. Padalino, L. De Gennaro, A. Cuculo, L. Ziccardi, P.L. Pellegrino, and M. Di Biase. 2009. Acute phase proteins activation in subjects with coronary atherosclerosis and micro-vessel coronary circulation impairment. Journal of Thrombosis and Thrombolysis 28: 50–56.PubMedCrossRef
Metadaten
Titel
Subacute Inflammatory Activation in Subjects with Acute Coronary Syndrome and Left Ventricular Dysfunction
verfasst von
Luisa De Gennaro
Natale Daniele Brunetti
Deodata Montrone
Fiorella De Rosa
Andrea Cuculo
Matteo Di Biase
Publikationsdatum
01.02.2012
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 1/2012
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-011-9326-4

Weitere Artikel der Ausgabe 1/2012

Inflammation 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.